Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
A completed clinical trial update presenting results from a survey of cabozantinib use in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN) [Phase 2]
Phase 2 AXIPAN trial of Axitinib for downstaging large renal tumors not suitable for partial nephrectomy has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]
Clinical trial update for TT-10 and TT-4 (Portage Biotech) exploring single-agent and combination therapy in advanced solid tumors, with rec…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study) [Phase 3]
Completed Phase 3 trial evaluating robot-assisted partial nephrectomy with and without mixed reality guidance (REALITATEM Study) for renal c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Empa PASS on Urinary Tract Malignancies
Completed post-authorization safety study (PASS) evaluating empagliflozin for urinary tract malignancies with results posted.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)
A Japanese retrospective study (J-DART2) reports treatment outcomes for renal cell carcinoma patients treated with the combination of avelum…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial) [Phase 2]
A Phase 2 trial of lenvatinib plus pembrolizumab in locally advanced or metastatic non-clear cell renal cell carcinoma was terminated. Resul…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating atezolizumab in combination with entinostat and bevacizumab in advanced renal cell carcinoma; the study …
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating nivolumab in combination with metformin for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
A completed clinical trial evaluated a CT-based deep learning model for predicting complications during partial nephrectomy. The study popul…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]
A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was termina…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
A completed clinical trial evaluating nivolumab in metastatic renal cell carcinoma, examining regulatory T cell function, T-cell access, and…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pre-incisional ketorolac in surgery for non-small cell lung cancer or renal cell carcinoma has been terminated, wit…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared [NA]
This clinical trial update reports on Nephrogreen, evaluating ex vivo appearances of renal tumors under near-infrared light; the study (NCT0…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma [NA]
This entry documents the completion of a University of Rochester clinical trial evaluating software-based monitoring of treatment-related to…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer [Phase 1]
Phase 1 trial completed evaluating uptake of the radiotracer [68Ga]P16-093 in metastatic prostate cancer and metastatic renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]
Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/meta…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors [Phase 1]
Phase 1 interventional trial evaluating INCB 99280 in combination with ipilimumab in select solid tumors has been terminated. The study, spo…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size
A completed clinical trial comparing percutaneous tumor ablation with partial nephrectomy for small renal masses, assessing how histologic v…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
This is a completed real-world clinical trial evaluating the combination of nivolumab and ipilimumab for advanced or metastatic renal cell c…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
A completed Latin American multicenter study characterizes clinicopathological features and outcomes of renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating high-dose interleukin-2 in combination with an anti-PD-1 therapy to overcome resistance in metastatic melanoma and …
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers [Phase 1]
Phase 1 study of cosibelimab (CK-301) as a single-agent therapy in adults with advanced cancers; the trial status is active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer [EARLY_Phase 1]
This early-phase 1 trial update reports completion of a study evaluating daratumumab in patients with muscle-invasive bladder cancer and met…